Prelude Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Buy |
|
|||||
|
2025
Q1 | $242K | Buy |
|
|||||
|
2024
Q4 | $263K | Sell |
|
|||||
|
2024
Q3 | $401K | Sell |
|
|||||
|
2024
Q2 | $601K | Buy |
|
|||||
|
2024
Q1 | $74.9K | Sell |
|
|||||
|
2023
Q4 | $89.1K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $33K | Buy |
|
|||||
|
2017
Q3 | $5K | Sell |
|
|||||
|
2017
Q2 | $9K | Buy |
|
|||||
|
2015
Q4 | – | Hold |
|
|||||
|
2015
Q3 | – | Hold |
|